2018-2023 India Capecitabine Market Report (Status and Outlook)

Publisher Name :
Date: 07-Jun-2018
No. of pages: 87

In 2017, the Capecitabine market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.

In India market, the top players include

- Roche

- Teva

- Mylan

- Hikma

- Hengrui Medicine

- Cipla

- Reliance Group

- Hetero

Split by product types/category, covering

- 500 mg

- 150 mg

Split by applications/end use industries, covers

- Breast Cancer

- Colorectal cancer

- Stomach Cancer

2018-2023 India Capecitabine Market Report (Status and Outlook)

Table of Contents

2018-2023 India Capecitabine Market Report (Status and Outlook)
1 Capecitabine Market Overview
1.1 Product Overview and Scope of Capecitabine
1.2 Capecitabine Market Segment by Types
1.2.1 India Capecitabine Sales Present Situation and Outlook by Types (2013-2023)
1.2.2 India Capecitabine Sales Market Share by Types in 2017
1.2.3 500 mg
1.2.3.1 Major Players of 500 mg
1.2.4 150 mg
1.2.4.1 Major Players of 150 mg
1.3 India Capecitabine Market Segment by Applications/End Use Industries
1.3.1 India Capecitabine Sales Present Situation and Outlook by Applications/End Industrials (2013-2023)
1.3.2 India Capecitabine Sales Market Share by Applications in 2017
1.3.2 Breast Cancer
1.3.3 Colorectal cancer
1.3.4 Stomach Cancer
1.4 India Capecitabine Overview and Market Size (Value) (2013-2023)
1.4.1 India Market Capecitabine Overview
1.4.2 India Capecitabine Market Size (Value and Volume) Status and Forecast (2013-2023)
2 India Capecitabine Sales, Revenue (Value) and Market Share by Players
2.1 India Capecitabine Sales and Market Share by Players (2013-2018)
2.2 India Capecitabine Revenue and Market Share by Players (2013-2018)
2.3 India Capecitabine Average Price by Players in 2017
2.4 India Capecitabine Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Capecitabine Market Competitive Situation and Trends
2.5.1 Capecitabine Market Concentration Rate
2.5.2 Capecitabine Market Share of Top 3 and Top 5 Players in 2017
2.5.3 Mergers & Acquisitions, Expansion
3 India Capecitabine Sales, Revenue (Value) by Type and Application (2013-2018)
3.1 India Capecitabine Sales, Revenue, Market Share and Price by Type (2013-2018)
3.1.1 India Capecitabine Sales and Market Share by Type (2013-2018)
3.1.2 India Capecitabine Revenue and Market Share by Type (2013-2018)
3.1.3 India Capecitabine Price by Type (2013-2018)
3.2 India Capecitabine Sales and Market Share by Application (2013-2018)
3.3 India Market Capecitabine Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
4 India Capecitabine Players Profiles and Sales Data
4.1 Roche
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Capecitabine Product Types, Application and Specification
4.1.2.1 Type 1
4.1.2.2 Type 2
4.1.3 Roche Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.1.4 Main Business/Business Overview
4.1.5 Roche News
4.2 Teva
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Capecitabine Product Types, Application and Specification
4.2.2.1 Type 1
4.2.2.2 Type 2
4.2.3 Teva Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.2.4 Main Business/Business Overview
4.2.5 Teva News
4.3 Mylan
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Capecitabine Product Types, Application and Specification
4.3.2.1 Type 1
4.3.2.2 Type 2
4.3.3 Mylan Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.3.4 Main Business/Business Overview
4.3.5 Mylan News
4.4 Hikma
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Capecitabine Product Types, Application and Specification
4.4.2.1 Type 1
4.4.2.2 Type 2
4.4.3 Hikma Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.4.4 Main Business/Business Overview
4.4.5 Hikma News
4.5 Hengrui Medicine
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Capecitabine Product Types, Application and Specification
4.5.2.1 Type 1
4.5.2.2 Type 2
4.5.3 Hengrui Medicine Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.5.4 Main Business/Business Overview
4.5.5 Hengrui Medicine News
4.6 Cipla
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 Capecitabine Product Types, Application and Specification
4.6.2.1 Type 1
4.6.2.2 Type 2
4.6.3 Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.6.4 Main Business/Business Overview
4.6.5 Cipla News
4.7 Reliance Group
4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.7.2 Capecitabine Product Types, Application and Specification
4.7.2.1 Type 1
4.7.2.2 Type 2
4.7.3 Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.7.4 Main Business/Business Overview
4.7.5 Reliance Group News
4.8 Hetero
4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.8.2 Capecitabine Product Types, Application and Specification
4.8.2.1 Type 1
4.8.2.2 Type 2
4.8.3 Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.8.4 Main Business/Business Overview
4.8.5 Hetero News
5 India Capecitabine Market Forecast (2018-2023)
5.1 India Capecitabine Sales, Revenue and Price Forecast (2018-2023)
5.1.1 India Capecitabine Sales and Growth Rate Forecast (2018-2023)
5.1.2 India Capecitabine Revenue and Growth Rate Forecast (2018-2023)
5.1.3 India Capecitabine Price Trend Forecast (2018-2023)
5.2 India Capecitabine Sales Forecast by Type (2018-2023)
5.3 India Capecitabine Sales Forecast by Application (2018-2023)
6 Production Cost Analysis of Capecitabine
6.1 Main Raw Materials of Capecitabine
6.1.1 List of Capecitabine Main Raw Materials
6.1.2 Capecitabine Main Raw Materials Price Analysis
6.1.3 Capecitabine Raw Materials Major Suppliers
6.1.4 Capecitabine Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Capecitabine
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Production Expenses
6.3 Capecitabine Manufacturing Process/Method
7 Value Chain, Purchasing Strategy and Downstream Buyers
7.1 Capecitabine Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Capecitabine Major Players in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Sales Channel
8.1.1 Direct Sales
8.1.2 Indirect Sales
8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Capecitabine Distributors/Traders List in India
9 Market Influences Factors Analysis
9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Data Source

List of Tables and Figures

Figure Picture of Capecitabine
Table Product Specifications of Capecitabine
Figure India Capecitabine Sales (volume) for Each Type (2013-2023)
Figure India Capecitabine Sales Market Share by Types in 2017
Table Types of Capecitabine
Figure Product Picture of 500 mg
Table Major Players of 500 mg
Figure Product Picture of 150 mg
Table Major Players of 150 mg
Figure India Capecitabine Sales Present Situation and Outlook by Applications (2013-2023)
Figure India Capecitabine Sales Market Share by Applications in 2017
Table Applications of Capecitabine
Figure Breast Cancer Examples
Figure Colorectal cancer Examples
Figure Stomach Cancer Examples
Figure India Capecitabine Revenue (Million USD) Status and Forecast (2013-2023)
Figure India Capecitabine Sales (Volume) Status and Forecast (2013-2023)
Table India Capecitabine Sales by Players (2013-2018)
Table India Capecitabine Sales Market Share (%) by Players (2013-2018)
Figure India Capecitabine Sales Market Share by Players in 2016
Figure India Capecitabine Sales Market Share by Players in 2017
Table India Capecitabine Revenue (Million USD) by Players (2013-2018)
Table India Capecitabine Revenue Market Share (%) by Players (2013-2018)
Figure India Capecitabine Revenue Market Share by Players in 2016
Figure India Capecitabine Revenue Market Share by Players in 2017
Figure India Capecitabine Average Price by Players in 2017
Table India Capecitabine Manufacturing Base Distribution and Sales Area by Players
Table Players Capecitabine Product Types
Figure Capecitabine Market Share of Top 3 Players in 2017
Figure Capecitabine Market Share of Top 5 Players in 2017
Table India Capecitabine Sales by Type (2013-2018)
Table India Capecitabine Sales Market Share by Type (2013-2018)
Figure India Capecitabine Sales Market Share by Type in 2013
Figure India Capecitabine Sales Market Share by Type in 2017
Table India Capecitabine Revenue (Million USD) by Type (2013-2018)
Table India Capecitabine Revenue Market Share by Type (2013-2018)
Figure India Capecitabine Revenue Market Share by Type in 2013
Figure India Capecitabine Revenue Market Share by Type in 2017
Table India Capecitabine Price by Type (2013-2018)
Table India Capecitabine Sales by Application (2013-2018)
Table India Capecitabine Sales Market Share by Application (2013-2018)
Figure India Capecitabine Sales Market Share by Application (2013-2018)
Figure India Capecitabine Sales Market Share by Application in 2017
Table India Market Capecitabine Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Capecitabine Market Share (2012-2017)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Capecitabine Market Share (2012-2017)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mylan Capecitabine Market Share (2012-2017)
Table Hikma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hikma Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hikma Capecitabine Market Share (2012-2017)
Table Hengrui Medicine Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hengrui Medicine Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hengrui Medicine Capecitabine Market Share (2012-2017)
Table Cipla Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Cipla Capecitabine Market Share (2012-2017)
Table Reliance Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Reliance Group Capecitabine Market Share (2012-2017)
Table Hetero Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hetero Capecitabine Market Share (2012-2017)
Figure India Capecitabine Sales and Growth Rate Forecast (2018-2023)
Figure India Capecitabine Revenue and Growth Rate Forecast (2018-2023)
Figure India Capecitabine Price Trend Forecast (2018-2023)
Table India Capecitabine Sales Forecast by Type (2018-2023)
Figure India Capecitabine Sales Market Share Forecast by Type (2018-2023)
Figure India Capecitabine Sales Market Share Forecast by Type in 2023
Table India Capecitabine Sales Forecast by Application (2018-2023)
Figure India Capecitabine Sales Market Share Forecast by Application (2018-2023)
Figure India Capecitabine Sales Market Share Forecast by Application in 2023
Table Production Base and Market Concentration Rate of Raw Material
Figure Capecitabine Main Raw Materials Price Trend
Table Capecitabine Raw Materials Major Suppliers List
Figure Production Cost Structure of Capecitabine
Figure Capecitabine Manufacturing Process/Method
Figure Capecitabine Value Chain Analysis
Table Raw Materials Sources of Capecitabine Major Players in 2017
Table Major Buyers of Capecitabine
Table Capecitabine Distributors/Traders List in India
  • 2018-2023 Global Hydroxycarbamide Consumption Market Report
    Published: 20-Aug-2018        Price: US 4660 Onwards        Pages: 163
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Hydroxycarbamide market for 2018-2023. Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Common side effects include bone marrow suppression, fevers, loss of app......
  • Global and India Cytotoxic Drug Market Research by Company, Type & Application 2013-2025
    Published: 19-Aug-2018        Price: US 2000 Onwards        Pages: 86
    Summary Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic' and ‘cytotoxic' are often used interchangeably.......
  • Global and India Lentinan Market Research by Company, Type & Application 2013-2025
    Published: 18-Aug-2018        Price: US 2000 Onwards        Pages: 114
    Summary Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer. Market Segment as follows: By Type - Food Grade - Pharmaceutical Grade - Others By Application - Food additive - Health product field - Anti-cancer drug - Others By Company - Ajinomoto - Elicityl......
  • Global Erlotinib Hydrochloride Market Insights, Forecast to 2025
    Published: 15-Aug-2018        Price: US 3900 Onwards        Pages: 99
    This report studies the global market size of Erlotinib Hydrochloride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Erlotinib Hydrochloride in these regions. This research report categorizes the global Erlotinib Hydrochloride market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, mark......
  • Global and India Cancer Treatment Drugs Market Research by Company, Type & Application 2013-2025
    Published: 15-Aug-2018        Price: US 2000 Onwards        Pages: 120
    Summary Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Market Segment as follows: By Type - Chemotherapy - Targeted Therapy - Immunotherapy (Biologic Therapy) - Hormonal Therapy - Others By Application - Blood Cancer - Breast Cancer - ......
  • Global Capecitabine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 134
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Capecitabine Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 135
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global and India Capecitabine Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 99
    Summary Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Market Segment as follows: By Type - 500 mg - 150 mg By Application - Breast Cancer - Colorectal cancer - Stomach Cancer ......
  • Global and India Mitomycin C Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 102
    Summary Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.). Market Segment as follows: By Type - 2 Mg - 10 Mg - 40 Mg - Others By Application - Cancer Trea......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs